Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Deniz Aksu Arıca, Turkan Ozturk Topcu, Leyla Baykal Selçuk, Savas Yaylı, Unzile Seyman, Evren Fidan, Sevgi Bahadır & Halil Kavgacı. (2017) Assessment of demodex presence in acne-like rash associated with cetuximab. Cutaneous and Ocular Toxicology 36:3, pages 220-223.
Read now
Read now
Jian Zheng, Xiaoru Bai, Chengyu Hong, Hong Gao & Xiaoling Li. (2016) Meta-analysis of the incidence and risk of arterial and venous thromboembolic events associated with anti-EGFR agents in non-small-cell lung cancer patients. Expert Review of Clinical Pharmacology 9:10, pages 1389-1395.
Read now
Read now
Articles from other publishers (10)
Wei-xiang Qi, Shengguang Zhao & Jiayi Chen. (2020) Risk factors for developing cardiac toxicities in cancer patients treated with panitumumab combination therapy. Future Oncology 16:19, pages 1359-1370.
Crossref
Crossref
Mei Mei, Yu-Huan Chen, Tian Meng, Ling-Han Qu, Zhi-Yong Zhang & Xiao Zhang. (2020)
Comparative efficacy and safety of radiotherapy/cetuximab
versus
radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data
. Therapeutic Advances in Medical Oncology 12, pages 175883592097535.
Crossref
Crossref
Katsuhiro Uzawa, Atsushi Kasamatsu, Tomoaki Saito, Akihiro Kita, Yuki Sawai, Yuriko Toeda, Kazuyuki Koike, Dai Nakashima, Yosuke Endo, Masashi Shiiba, Yuichi Takiguchi & Hideki Tanzawa. (2019) Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects. Experimental Cell Research 376:2, pages 210-220.
Crossref
Crossref
Jing Li & Hengxiu Yan. (2018) Skin toxicity with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of 65 randomized controlled trials. Cancer Chemotherapy and Pharmacology 82:4, pages 571-583.
Crossref
Crossref
Yunhong Tian, Jie Lin, Yunming Tian, Guoqian Zhang, Xing Zeng, Ronghui Zheng, Weijun Zhang & Yawei Yuan. (2018) Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis of randomized controlled trials. International Journal of Cancer 142:11, pages 2198-2206.
Crossref
Crossref
Bo Zhang, Chenyan Fang, Dehou Deng & Liang Xia. (2018) Research progress on common adverse events caused by targeted therapy for colorectal cancer (Review). Oncology Letters.
Crossref
Crossref
Jianhong Zhu, Wenxia Zhao, Dan Liang, Guocheng Li, Kaifeng Qiu, Junyan Wu & Jianfang Li. (2017) Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial. International Journal of Clinical Oncology 23:2, pages 389-399.
Crossref
Crossref
Yadi Li, Xiangang Fang, Xiaoqian Zhou, Suying Geng, Yuxin Wang & Xiumin Yang. (2017)
Pathogenicity of
Conidiobolus coronatus
and
Fusarium solani
in mouse models
. Mycoses 60:6, pages 394-401.
Crossref
Crossref
Tomohiro Enokida, Shinya Suzuki, Tetsuro Wakasugi, Tomoko Yamazaki, Susumu Okano & Makoto Tahara. (2016) Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab. Frontiers in Oncology 6.
Crossref
Crossref
Wei-Xiang Qi, Shen Fu, Qing Zhang & Xiao-Mao Guo. (2014) Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysis. BMC Medicine 12:1.
Crossref
Crossref